| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 05/03/2005 | US6887202 Systems and methods for monitoring health and delivering drugs transdermally |
| 05/03/2005 | US6886576 Method of controlling the flow in a flow system |
| 05/03/2005 | US6886452 System and method of leavening with carbon dioxide monitoring |
| 05/03/2005 | US6886392 Single ball bearing lubricant and material evaluator |
| 05/03/2005 | CA2334584C Filtration and extraction device and method of using the same |
| 05/03/2005 | CA2179823C Method of assay using two distinguishable types of particles |
| 05/03/2005 | CA2147623C Novel p-selectin ligand protein |
| 05/03/2005 | CA2128215C Autotaxin: motility stimulating protein useful in cancer diagnosis and therapy |
| 04/30/2005 | CA2485854A1 Enzime activities and ph tests for the determination of the risk of obstetric and gynecologic complications in samples of body fluids of women |
| 04/28/2005 | WO2005038734A2 Authentication of products using molecularly imprinted polymers |
| 04/28/2005 | WO2005038618A2 Lead molecule cross-reaction prediction and optimization system |
| 04/28/2005 | WO2005038596A2 Method and apparatus for estimation of the electrostatic affinity between molecules using a basis expansion |
| 04/28/2005 | WO2005038466A1 Device for analysing bulk goods |
| 04/28/2005 | WO2005038465A2 Anti-vascular and anti-proliferation methods, therapies, and combinations employing specific tyrosine kinase inhibitors |
| 04/28/2005 | WO2005038464A2 Method for detecting the presence of an/or strain typing a tse |
| 04/28/2005 | WO2005038463A1 Method for the detection of a neurological or psychiatric, demential disease, especially alzheimer's disease by use of cholecystokinin (cck) -molecules, corresponding substances and detection reagents |
| 04/28/2005 | WO2005038462A1 Method for prognostic evaluation of carcinoma using anti-p-lap antibody |
| 04/28/2005 | WO2005038461A1 Method for the diagnosis of diseases by determining apolipoprotein ci |
| 04/28/2005 | WO2005038460A2 Site-specific labeling of affinity tags in fusion proteins |
| 04/28/2005 | WO2005038459A2 Bridged element for detection of a target substance |
| 04/28/2005 | WO2005038458A1 Method of pretreating sample and immunological assay method using the same |
| 04/28/2005 | WO2005038457A1 Method of separating and assaying adiponectin multimer |
| 04/28/2005 | WO2005038456A1 Tool for analyzing specimen |
| 04/28/2005 | WO2005038455A1 A novel assay for screening antipsychotic drugs |
| 04/28/2005 | WO2005038454A1 In vitro method for the diagnosis of cardiovascular functionality of bone marrow precursor cells (bmp) and/or circulation precursor cells derived from blood (bdp) |
| 04/28/2005 | WO2005038453A1 Early assessment of motor recovery in spinal cord injury patients |
| 04/28/2005 | WO2005038452A1 Method and apparatus for analysis of molecular combination based on computations of shape complementarity using basis expansions |
| 04/28/2005 | WO2005038447A1 Apparatus and method for testing combustion |
| 04/28/2005 | WO2005038442A1 Method of measuring surface plasmon resonance and noble metal compound for use in the method |
| 04/28/2005 | WO2005038431A2 Method and device for partitioning a molecule |
| 04/28/2005 | WO2005038409A2 Flow assurance monitoring |
| 04/28/2005 | WO2005038057A1 Classification of patients having diffuse large b-cell lymphoma based upon gene expression |
| 04/28/2005 | WO2005038055A1 Multiplexing array techniques |
| 04/28/2005 | WO2005038050A1 Method for identification of suitable fragmentation sites in a reporter protein |
| 04/28/2005 | WO2005038045A1 Method and kit for measuring the activity of factor xiii |
| 04/28/2005 | WO2005038044A1 Method of treating cells |
| 04/28/2005 | WO2005038043A2 Methods of detecting poly (adp-ribose) polymerase and other nad+utilizing enzymes |
| 04/28/2005 | WO2005038042A2 Systems and methods for assessing neuronal degeneration |
| 04/28/2005 | WO2005038027A1 Transgenic nonhuman mammal |
| 04/28/2005 | WO2005038026A1 Method of typing mutation |
| 04/28/2005 | WO2005038006A2 Chimeric metabotropic glutamate receptors and uses thereof |
| 04/28/2005 | WO2005038005A2 Shc proteins as therapeutic targets in proliferative diseases |
| 04/28/2005 | WO2005038000A2 T cell epitopes useful in mycobacterium tuberculosis vaccine and as diagnostic tools and methods for identifying same |
| 04/28/2005 | WO2005037984A1 Cell handling device, human tissue regeneration composition, and human tissue regeneration method |
| 04/28/2005 | WO2005037983A1 Nucleic acid separation purification cartridge and process for producing the same |
| 04/28/2005 | WO2005037881A1 Affinity resin |
| 04/28/2005 | WO2005037868A2 Methods of treating nfat-related disorders |
| 04/28/2005 | WO2005037859A2 Fluorescence assay for kinase activity |
| 04/28/2005 | WO2005037858A2 Template-directed assembly of receptor signaling complexes |
| 04/28/2005 | WO2005037857A2 Method of protein analysis by maldi using protein fragmentation with peroxycarbonates |
| 04/28/2005 | WO2005037699A1 Method for determining the effects of fancy yarn |
| 04/28/2005 | WO2005037440A1 Magnetic enrichment method, a reactor unit for micro particles and a magnet unit |
| 04/28/2005 | WO2005037439A2 Method and a device for treating microparticles |
| 04/28/2005 | WO2005037323A2 Use of gro to treat or prevent inflammation |
| 04/28/2005 | WO2005037312A2 Binding molecules for the extra-domain b of fibronectin, used for the detection of atherosclerotic plaques |
| 04/28/2005 | WO2005037305A1 Therapeutic uses of chemokine variants |
| 04/28/2005 | WO2005037293A1 Immunomodulating compositions and uses therefor |
| 04/28/2005 | WO2005037231A2 Methods of detecting and treating facioscapulohumeral muscular dystrophy |
| 04/28/2005 | WO2005037229A2 Methods and compositions for modulating gamete adhesion |
| 04/28/2005 | WO2005037228A2 Halogen phosphonate monoesters |
| 04/28/2005 | WO2005037210A2 Photocleavable isotope-coded affinity tags |
| 04/28/2005 | WO2005037204A2 Ntrk1 genetic markers associated with age of onset of alzheimer's disease |
| 04/28/2005 | WO2005037195A2 Compounds and methods for treating and preventing exercise-induced cardiac arrhythmias |
| 04/28/2005 | WO2005037194A2 Collagen interactions with prostate cancer cells |
| 04/28/2005 | WO2005037190A2 Multiplex vaccines |
| 04/28/2005 | WO2005037189A2 Cytoplasmic activity of retinoid x receptor and its regulation by ligands and dimerization |
| 04/28/2005 | WO2005037083A2 Mn/ca ix and cancer prognosis |
| 04/28/2005 | WO2005037071A2 Receptor tyrosine kinase signaling pathway analysis for diagnosis and therapy |
| 04/28/2005 | WO2005037059A2 Multi-marker screening protocol for fetal abnormalities |
| 04/28/2005 | WO2005037056A2 Method for the detection of a biomolecule in a test sample |
| 04/28/2005 | WO2005037053A2 High throughput screening of aptamer libraries for specific binding to proteins on viruses and other pathogens |
| 04/28/2005 | WO2005037052A2 Binding assay with labelled bispidine variant |
| 04/28/2005 | WO2005024434A3 Test |
| 04/28/2005 | WO2005024382A3 Nanodevices employing combinatorial artificial receptors |
| 04/28/2005 | WO2005024375A3 Sample module comprising a spare battery |
| 04/28/2005 | WO2005024059A3 Methods for identifying compounds for inhibiting fever |
| 04/28/2005 | WO2005023291A3 Use of glp1-agonists in the treatment of patients with type i diabetes |
| 04/28/2005 | WO2005019431A3 Selective inhibition of toll-like receptor-2 |
| 04/28/2005 | WO2005019266A3 Human anti-ngf neutralizing antibodies as selective ngf pathway inhibitors |
| 04/28/2005 | WO2005017521A3 Techniques for recording signals |
| 04/28/2005 | WO2005016398A3 Molecular probe and material for the detection of an analyte, and use thereof |
| 04/28/2005 | WO2005013889A3 Truncated fragments of alpha-synuclein in lewy body disease |
| 04/28/2005 | WO2005013849A3 Methods for managing animal processing operations |
| 04/28/2005 | WO2005013666A3 Novel translocation assay |
| 04/28/2005 | WO2005007744A9 Methods and systems for creating and using comprehensive and data-driven simulations of complex biological systems for pharmacological and industrial applications |
| 04/28/2005 | WO2005007688A3 Human prostaglandin fp receptor variants and methods of using same |
| 04/28/2005 | WO2005005990A3 Inverse labeling method for the rapid identification of marker target proteins |
| 04/28/2005 | WO2005003371A3 Erk7 and erk8, novel diagnostic markers for cancer |
| 04/28/2005 | WO2005003292A3 Composition and method for self-assembly and mineralization of peptide amphiphiles |
| 04/28/2005 | WO2005003161A3 Human secreted proteins |
| 04/28/2005 | WO2005001413A3 Method and apparatus for formulating and controlling chemical concentrations in a gas mixture |
| 04/28/2005 | WO2004113689A3 Device and method for automatically monitoring the operating condition of a lubricant of a machine or machine part |
| 04/28/2005 | WO2004112820A3 Peptides and peptidomimetics having immune-modulating, anti-inflammatory, and anti-viral activity |
| 04/28/2005 | WO2004112570A3 Detection of survivin in the biological fluids of cancer patients |
| 04/28/2005 | WO2004111180A3 Methods and compositions for selectively enriching microbes |
| 04/28/2005 | WO2004110390A3 Anti-cd74 immunoconjugates and methods |
| 04/28/2005 | WO2004110250A3 Diagnostic method for atherosclerosis |
| 04/28/2005 | WO2004104595A3 Diagnostics and therapeutics for diseases associated with x-pro dipeptidase (pepd) |
| 04/28/2005 | WO2004104552A3 Apparatus and method for process monitoring |
| 04/28/2005 | WO2004102191A3 Serum protein profiling for the diagnosis of epithelial cancers |